Workshop: Microphysiological Systems: Bridging Human and Animal Research
News and BlogOn Wednesday, January 20th, 2021, at 11:10 am ET, AxoSim’s Chief Science Officer, Michael J. Moore, PhD, will be presenting at The […]
Read MoreAxoSim empowers advancements in human neuroscience and accelerates the drug development process through our drug discovery platforms, NerveSim™ and BrainSim™
Learn MoreOur technology enables researchers to predict human outcomes in the lab. We deliver accurate preclinical testing to help develop safer, more effective drugs.
Almost 90% of drugs that look promising in animal models fail when tested in humans, driving up the average cost and time of new drug development to $2.6 billion and 10 years or more. We deliver predictive human data in just weeks and at a fraction of the cost of in vivo studies.
Achieve the predictive readouts critical to your R&D success. We deliver clinically-relevant functional and structural metrics to improve success rates.
AxoSim's NerveSim™ Platform, powered by Nerve-on-a-Chip® facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.
BrainSim™ is a high quality 3D miniature brain organoid designed to serve as a human-relevant model in preclinical drug discovery.
On Wednesday, January 20th, 2021, at 11:10 am ET, AxoSim’s Chief Science Officer, Michael J. Moore, PhD, will be presenting at The […]
Read MoreDecember 10, 2020 We present a nontraditional fabrication technique for the realization of three-dimensional (3D) microelectrode arrays (MEAs) capable of interfacing with […]
Read More2020 has been a rough year in so many ways – but this year, we’ve also seen many outstanding advances here at […]
Read MoreOn Tuesday, December 8th, at 9am EST, AxoSim Consulting VP of Scientific Affairs, Thomas Hartung, MD, PhD, will be speaking on a […]
Read More